RAPIA Survey Manual (WHO)
“The importance of health systems and access to medicines for NCDs cannot be negated. Without a shift in focus from acute to chronic care, health systems throughout the world will be unable to address the increasing burden of NCDs […] This manual delivers an approach that helps achieve an understanding with regards to existing barriers in health systems and access to medicines and contributes to achieving the Global Strategy Action Plan on NCDs as well as the larger goal of the enjoyment of the highest attainable standard of physical and mental health for all.”
This survey manual, developed in 2012 by the International Insulin Foundation (IIF), provides a methodology to investigate access to care for NCDs, including necessary medicines and supplies. Considering the low investment and prioritization of NCDs globally, a mixed methodological survey collection tool allows for different stakeholders involved in NCDs in low- and middle-income countries to plan and conduct surveys to explore current patterns of, and barriers to, effective management. With this information available, evidence based recommendations can be made in a short timescale and with limited resources.
The manual offers the following main sections:
- Initial preparations and sampling methods
- Data collection tools and fieldwork preparations
- Data collection, entry and analysis
- Reporting and dissemination
- Follow on activities, including policy implications and cross country comparisons
The survey process is expected to raise awareness of the target disease (type 1 diabetes) and to increase the availability of the data that are required for this survey. The survey team may be able to act as a catalyst to facilitate discussion between different stakeholders and provide much needed evidence to inform policy change into health systems.
More information on NCD survey tools can be found here:
- Rapid Assessment Protocol for Insulin Access
- How to investigate drug use in health facilities
- WHO/HAI Survey for the Price and Availability of Medicines